CRP and peripheral arterial disease: Physiologically, CRP’s pro-inflammatory properties are evidenced by the presence of anti-(m)CRP antibodies in several autoimmune conditions, such as lupus nephritis, peripheral artery disease (PAD), and skin-related disorders (16–18).